RECQL3 Antibody

What is RECQL3 and why is it important in molecular biology research?

RECQL3, also known as BLM (Bloom syndrome protein), RECQ2, or RecQ-like DNA helicase BLM, is an ATP-dependent DNA helicase that unwinds double-stranded DNA in a 3'-5' direction. It plays crucial roles in multiple DNA maintenance pathways, including replication, repair, and recombination. The protein is particularly important for:

• Participating in DNA replication and repair processes

• 5'-end resection during double-strand break repair

• Stimulating DNA 4-way junction branch migration

• Dissolving DNA Holliday junctions

• Binding single-stranded DNA, forked duplex DNA, and Holliday junction DNA

• Unwinding G-quadruplex DNA structures

• Negatively regulating sister chromatid exchange

• Promoting restart of stalled replication forks

In the context of microbial infections, RECQL3 has been shown to eliminate nuclear HIV-1 cDNA, thereby suppressing immune sensing and proviral hyper-integration . Due to its crucial role in maintaining genomic stability, mutations in the BLM gene cause Bloom's syndrome, characterized by growth deficiency, immunodeficiency, and cancer predisposition.

What types of RECQL3 antibodies are available for research applications?

Several types of RECQL3/BLM antibodies are available for research purposes:

• Total RECQL3/BLM antibodies targeting various regions of the protein

• Phospho-specific antibodies targeting phosphorylated residues (e.g., phospho T99)

• Species-specific antibodies (most commonly recognizing human RECQL3/BLM)

• Antibodies with different host species (e.g., rabbit polyclonal antibodies)

• Antibodies validated for specific applications such as Western blotting, immunohistochemistry, and immunofluorescence

The choice depends on the specific research question, application, and experimental design. For instance, phospho-specific antibodies are particularly useful when studying post-translational modifications and signaling events affecting RECQL3 function.

What are the validated applications for RECQL3 antibodies?

RECQL3/BLM antibodies have been validated for various experimental applications:

• Western blotting (WB): For detecting RECQL3 in cell or tissue lysates and verifying protein size (approximately 159 kDa)

• Immunohistochemistry on paraffin-embedded sections (IHC-P): For examining RECQL3 expression in tissue samples

• Immunocytochemistry/Immunofluorescence (ICC/IF): For visualizing subcellular localization of RECQL3, particularly in the nucleus and nucleolus

• Immunoprecipitation: For isolating RECQL3 and its interacting partners

• Chromatin immunoprecipitation (ChIP): For studying RECQL3 binding to specific DNA regions

When selecting an antibody, researchers should verify that it has been validated for their specific application and species of interest.

How should I design experiments to investigate RECQL3's role in DNA repair pathways?

When investigating RECQL3's function in DNA repair, consider these key experimental approaches:

• Knockdown/Knockout studies: Use siRNA, shRNA, or CRISPR-Cas9 to reduce or eliminate RECQL3 expression, then assess the impact on:

  • DNA damage accumulation (using γH2AX staining)

  • Sensitivity to DNA damaging agents

  • Sister chromatid exchange frequency

  • Homologous recombination efficiency

• Complementation assays: Introduce wild-type or mutant RECQL3 into RECQL3-deficient cells to identify critical residues/domains.

• Helicase activity assays: Measure the unwinding of specifically designed DNA substrates:

  • Forked duplex DNA

  • Holliday junctions

  • G-quadruplex structures

• Protein interaction studies: Use co-immunoprecipitation with RECQL3 antibodies to identify interacting partners during DNA repair.

• Localization dynamics: Track RECQL3 recruitment to DNA damage sites using live-cell imaging with fluorescently tagged RECQL3 and time-lapse microscopy.

• DNA fiber analysis: Evaluate replication fork progression and restart in cells with altered RECQL3 function.

When using RECQL3 antibodies in these experiments, include appropriate controls such as RECQL3-deficient cells and blocking peptides to confirm antibody specificity .

What methodologies are optimal for studying phosphorylated forms of RECQL3?

To effectively study phosphorylated RECQL3:

• Selection of phospho-specific antibodies: Use antibodies that specifically recognize phosphorylated residues of interest, such as phospho T99 .

• Preservation of phosphorylation status:

  • Include phosphatase inhibitors in all lysis and extraction buffers

  • Use appropriate fixation methods that preserve phospho-epitopes

  • Process samples quickly and maintain cold temperatures

• Validation strategies:

  • Use lambda phosphatase treatment as a negative control

  • Include blocking peptides containing the phosphorylated and non-phosphorylated residue

  • Compare signals before and after treatments that affect phosphorylation status

• Kinase prediction and confirmation:

  • Use bioinformatics to predict potential kinases for your phosphorylation site

  • Perform in vitro kinase assays to confirm

  • Use kinase inhibitors to validate in cellular context

• Functional significance assessment:

  • Create phospho-mimetic (e.g., T99D) and phospho-dead (e.g., T99A) mutants

  • Perform rescue experiments in RECQL3-depleted cells

  • Assess effects on helicase activity, protein interactions, and localization

When using phospho-specific antibodies like anti-RECQL3 phospho T99, always confirm specificity using appropriate blocking peptides as demonstrated in the immunofluorescence and immunohistochemistry applications .

How can I optimize immunofluorescence protocols for detecting RECQL3 in different cell types?

For optimal immunofluorescence detection of RECQL3:

• Fixation optimization:

  • Test different fixatives: 4% paraformaldehyde (best for morphology), methanol (better for nuclear proteins), or a combination

  • Optimize fixation time (typically 10-20 minutes)

  • For phospho-epitopes, include phosphatase inhibitors

• Permeabilization considerations:

  • For nuclear proteins like RECQL3, thorough permeabilization is essential

  • Test different detergents (0.1-0.5% Triton X-100, 0.1-0.2% SDS)

  • Optimize permeabilization time (5-15 minutes)

• Blocking and antibody dilution:

  • Use 5-10% serum from the species of the secondary antibody

  • Include 0.1-0.3% BSA to reduce non-specific binding

  • For phospho-specific antibodies, test a range of dilutions (1/250-1/1000)

• Signal amplification:

  • For low-abundance proteins, consider tyramide signal amplification

  • Use high-sensitivity detection systems

• Counterstaining:

  • Include DAPI for nuclear visualization

  • Consider co-staining with markers of specific nuclear structures (nucleoli, PML bodies)

• Controls:

  • Negative controls: primary antibody omission, isotype controls

  • Blocking peptide controls, especially for phospho-specific antibodies

  • RECQL3-depleted cells as specificity controls

The published protocol for anti-RECQL3 phospho T99 antibody used a 1/500 dilution for HeLa cells with successful detection . Always validate your protocol for each cell type of interest.

How can RECQL3 antibodies be utilized to study Bloom's syndrome pathophysiology?

RECQL3/BLM antibodies are valuable tools for investigating Bloom's syndrome (BS) pathophysiology:

• Protein expression analysis:

  • Compare RECQL3 expression levels in patient-derived cells versus controls

  • Assess whether mutant RECQL3 proteins are expressed and stable

• Functional assays:

  • Evaluate DNA repair capacity using γH2AX foci resolution

  • Assess sister chromatid exchange rates (typically elevated in BS)

  • Measure G-quadruplex resolution capacity

• Transcriptome integration:

  • Correlate RECQL3 protein expression with transcriptome data

  • RNA-seq analysis from BS patients has revealed 216 differentially expressed genes related to immunological pathways

  • Focus on genes involved in B cell regulation, immune effector processes, and apoptosis control

• Protein interaction networks:

  • Use RECQL3 antibodies for co-immunoprecipitation to identify altered protein interactions in BS

  • Compare interactomes between wild-type and mutant RECQL3

• Therapeutic development:

  • Screen compounds that may stabilize mutant RECQL3 or compensate for its deficiency

  • Monitor RECQL3 expression and function in response to potential therapeutics

Recent RNA-seq studies of BS patients have interestingly shown that genes associated with immune response and apoptosis control present abnormal expression profiles, while DNA repair pathway genes showed similar expression to controls . This suggests that immunological dysregulation may play a more significant role in BS pathophysiology than previously thought.

What approaches should be used to investigate RECQL3's role in immunological processes?

Recent findings have revealed unexpected connections between RECQL3 and immunological processes that warrant thorough investigation:

• Transcriptome analysis integration:

  • RNA-seq data from BS patients showed dysregulation of 216 genes related to immunological pathways

  • Key pathways include positive regulation of B cell proliferation, interferon gamma-mediated signaling, immune effector processes, and viral response

• Immune cell phenotyping:

  • Use flow cytometry with RECQL3 antibodies to examine expression in different immune cell populations

  • Compare RECQL3 expression and localization in activated versus resting immune cells

• Functional immune assays:

  • Assess B cell activation and proliferation in RECQL3-deficient models

  • Measure cytokine production and responsiveness

  • Evaluate interferon responses

• Gene expression correlation studies:

  • Examine relationships between RECQL3 and key immune regulators identified in transcriptome studies

  • Focus on genes like FCGR1B, KLRC2, CIITA, MS4A1, and FCGR2C, which have been identified as differentially expressed in BS patients

• Viral response investigation:

  • Study RECQL3's role in eliminating nuclear HIV-1 cDNA

  • Assess impact on immune sensing and viral integration

• Apoptosis pathway analysis:

  • Investigate interactions between RECQL3 and apoptosis-related genes found dysregulated in BS (BCL2L1, CASP7, CDKN1A, E2F2, ITPR, CD274, TNFAIP6, TNFRSF25, TNFRSF13C, and TNFRSF17)

This research direction is particularly important as BS patients often present with immunodeficiency and recurrent infections, suggesting that RECQL3's role extends beyond canonical DNA repair functions.

What are the common challenges in Western blot detection of RECQL3 and how can they be overcome?

RECQL3/BLM is a high molecular weight protein (~159 kDa) that presents several challenges for Western blot detection:

• Protein transfer issues:

  • Problem: Inefficient transfer of high molecular weight proteins

  • Solution: Use wet transfer with lower methanol concentration (5-10%), extend transfer time, or employ semi-dry transfer systems designed for large proteins

• Protein degradation:

  • Problem: RECQL3 can be subject to proteolysis during sample preparation

  • Solution: Use fresh samples, keep them cold, include protease inhibitors, and avoid repeated freeze-thaw cycles

• Low endogenous expression:

  • Problem: RECQL3 may have low expression in some cell types

  • Solution: Load more protein (50-100 μg), use enhanced chemiluminescence substrates, or consider enrichment by immunoprecipitation

• Non-specific bands:

  • Problem: Additional bands appear near the target band

  • Solution: Optimize antibody dilution (test 1:500-1:5000), increase blocking duration, and include specific blocking peptides as controls

• Phosphorylation-specific detection:

  • Problem: Phospho-epitopes may be lost during sample preparation

  • Solution: Include phosphatase inhibitors in lysis buffers and compare with blocking peptide controls

For optimal results with anti-RECQL3 phospho T99 antibody, the recommended controls include using blocking peptides to confirm specificity, as demonstrated in the Western blot of HepG2 cell lysates where the specific 159 kDa band disappears in the presence of the blocking peptide .

How can antibody microarray approaches be optimized for RECQL3 detection in complex specimens?

For sensitive detection of RECQL3 and related proteins in complex specimens using antibody microarrays:

• Labeling strategies:

  • Indirect detection with NHS- or ULS-based fluorescein and biotin labels significantly outperforms direct fluorescent labeling for complex samples

  • Optimize labeling conditions to maintain protein functionality while ensuring sufficient tag incorporation

• Signal amplification:

  • Use secondary detection with anti-fluorescein or extravidin for enhanced sensitivity

  • Optimize concentrations of detection reagents (anti-fluorescein and extravidin) to maximize signal-to-noise ratio

• Solid support selection:

  • Choose appropriate surface chemistry that maintains antibody functionality

  • Consider hybrid polymeric thin film-coated slides for improved performance

• Incubation parameters:

  • Extend incubation times to improve binding kinetics, especially for low-abundance proteins

  • Optimize protein concentration to avoid saturation or insufficient signal

• Controls and normalization:

  • Include internal standard proteins for normalization

  • Use depleted samples as negative controls

  • Include gradient dilutions for standard curve generation

• Data analysis:

  • Apply robust statistical methods to identify significant changes

  • Use appropriate normalization methods to account for technical variation

When optimized properly, antibody microarray approaches can achieve femtomolar range sensitivity comparable to ELISA and Luminex methods, as demonstrated for cytokine detection . This makes them suitable for detecting even low-abundance proteins like RECQL3 in complex biological samples.

How can RECQL3 antibodies be used to investigate its role in cancer biology?

RECQL3/BLM antibodies are valuable tools for exploring the protein's functions in cancer:

• Expression profiling across cancer types:

  • Use immunohistochemistry with RECQL3 antibodies to analyze expression patterns in different tumor types

  • Correlate expression levels with clinical outcomes and genomic instability markers

• Functional studies in cancer models:

  • Compare RECQL3 activity in normal versus cancer cells

  • Assess cancer cells' dependency on RECQL3 for survival using knockdown approaches

  • Investigate synthetic lethality with other DNA repair deficiencies

• Replication stress response:

  • Study RECQL3 recruitment to stalled replication forks in cancer cells experiencing replication stress

  • Examine RECQL3 phosphorylation status as a marker of active DNA repair in tumors

• Therapeutic sensitivity prediction:

  • Evaluate whether RECQL3 expression or post-translational modifications correlate with sensitivity to:

    • DNA damaging chemotherapeutics

    • PARP inhibitors

    • ATR/CHK1 inhibitors

    • Other targeted therapies

• Combined biomarker applications:

  • Develop multiplexed detection systems incorporating RECQL3 with other DNA repair markers

  • Create predictive panels for therapeutic response

The connection between RECQL3 and cancer is particularly relevant because Bloom's syndrome patients have a significantly increased risk of developing cancer. Understanding how RECQL3 functions as a tumor suppressor could lead to new therapeutic strategies targeting DNA repair pathways in cancer.

What are the emerging applications of RECQL3 antibodies in virus-host interaction studies?

Recent discoveries about RECQL3's role in viral DNA elimination open exciting research directions:

• HIV-1 interaction studies:

  • Investigate RECQL3's mechanism in eliminating nuclear HIV-1 cDNA

  • Study how RECQL3 suppresses immune sensing and prevents proviral hyper-integration

  • Examine whether RECQL3 mutations affect HIV-1 infection outcomes

• Broader antiviral activity assessment:

  • Determine if RECQL3 acts against other retroviruses or DNA viruses

  • Study viral strategies that might counteract RECQL3 activity

• Immune signaling integration:

  • Explore how RECQL3's viral DNA elimination function connects to the immune response pathways identified in transcriptome studies

  • Focus on interferon-responsive gene regulation

• Therapeutic implications:

  • Investigate whether enhancing RECQL3 activity could serve as an antiviral strategy

  • Explore how existing antiretrovirals interact with RECQL3 function

• Methodological approaches:

  • Use RECQL3 antibodies for chromatin immunoprecipitation to identify viral DNA binding

  • Perform co-localization studies to visualize RECQL3 interaction with viral components

  • Conduct protein interaction studies to identify viral and host factors that modulate RECQL3's antiviral activity

This research area could reveal new insights into innate immunity against retroviruses and potentially identify novel therapeutic targets for viral infections.